Literature DB >> 1407003

Molecular structural basis of ligand selectivity for 5-HT2 versus 5-HT1C cortical receptors.

P A Pierce1, J Y Kim, S J Peroutka.   

Abstract

A molecular structural criterion of ligand selectivity for the 5-HT2 versus 5-HT1C receptor was hypothesized on the basis of radioligand binding data. Despite the large number of compounds which have been tested at both receptors, analysis of published data led to the identification of only five agents which are greater than 10-fold selective for the 5-HT2 versus the 5-HT1C receptor. Comparison of the two-dimensional structures revealed that, although these five compounds represent three distinct structural classes, they share a common structural feature located in the region hypothesized to be involved in receptor binding: a carbonyl or carboxyl oxygen interposed spatially between an aromatic ring and nitrogen atom. This structural feature was used to predict the relative selectivity of compounds that had not previously been analyzed at both the 5-HT2 and 5-HT1C receptors. All six drugs tested which contain the identified reactive carbonyl or carboxyl group were found to be selective for the 5-HT2 versus the 5-HT1C receptor with selectivity ratios ranging from 26 to 380. By contrast, three agents which are structurally similar but do not contain the reactive carbonyl or carboxyl group displayed equally high affinity for both receptor binding sites. Since the physiological roles of the 5-HT2 and 5-HT1C receptor are markedly different, it would be of potential clinical and scientific value to utilize this molecular structural feature to further identify chemical compounds which would selectively interact with only one of the two receptors.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1407003     DOI: 10.1007/bf00167563

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  70 in total

1.  [(125)I]LSD binding to serotonin and dopamine receptors in bovine caudate membranes.

Authors:  P R Hartig; M J Evans; A M Krohn; S A Leder; P C Sze; D A Stoffers
Journal:  Neurochem Int       Date:  1985       Impact factor: 3.921

2.  Pharmacological analysis of the behavioural and thermoregulatory effects of the putative 5-HT1 receptor agonist, RU 24969, in the rat.

Authors:  M D Tricklebank; D N Middlemiss; J Neill
Journal:  Neuropharmacology       Date:  1986-08       Impact factor: 5.250

3.  A common structural model for central nervous system drugs and their receptors.

Authors:  E J Lloyd; P R Andrews
Journal:  J Med Chem       Date:  1986-04       Impact factor: 7.446

4.  Indolealkylamine analogs share 5-HT2 binding characteristics with phenylalkylamine hallucinogens.

Authors:  R A Lyon; M Titeler; M R Seggel; R A Glennon
Journal:  Eur J Pharmacol       Date:  1988-01-19       Impact factor: 4.432

5.  Serotonin 5-HT1C receptors are expressed at high density on choroid plexus tumors from transgenic mice.

Authors:  K A Yagaloff; G Lozano; T van Dyke; A J Levine; P R Hartig
Journal:  Brain Res       Date:  1986-10-22       Impact factor: 3.252

6.  Graphics computer-aided receptor mapping as a predictive tool for drug design: development of potent, selective, and stereospecific ligands for the 5-HT1A receptor.

Authors:  M F Hibert; M W Gittos; D N Middlemiss; A K Mir; J R Fozard
Journal:  J Med Chem       Date:  1988-06       Impact factor: 7.446

7.  5-HT1C receptor-mediated stimulation of inositol phosphate production in pig choroid plexus. A pharmacological characterization.

Authors:  D Hoyer; C Waeber; P Schoeffter; J M Palacios; A Dravid
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-03       Impact factor: 3.000

8.  1-(1-Naphthyl)piperazine, a central serotonin agonist.

Authors:  R W Fuller; N R Mason; H D Snoddy; K W Perry
Journal:  Res Commun Chem Pathol Pharmacol       Date:  1986-01

9.  Interaction of arylpiperazines with 5-HT1A, 5-HT1B, 5-HT1C and 5-HT1D receptors: do discriminatory 5-HT1B receptor ligands exist?

Authors:  P Schoeffter; D Hoyer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-06       Impact factor: 3.000

10.  Serotonin increases the production of inositol phosphates and mobilises calcium via the 5-HT2 receptor in A7r5 smooth muscle cells.

Authors:  V M Doyle; J A Creba; U T Rüegg; D Hoyer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-06       Impact factor: 3.000

View more
  3 in total

1.  The effects of paroxetine given repeatedly on the 5-HT receptor subpopulations in the rat brain.

Authors:  J Maj; M Bijak; M Dziedzicka-Wasylewska; R Rogoz; Z Rogóz; G Skuza; T Tokarski
Journal:  Psychopharmacology (Berl)       Date:  1996-09       Impact factor: 4.530

2.  Behavioural interactions between 5-hydroxytryptophan, neuroleptic agents and 5-HT receptor antagonists in modifying rodent responding to aversive situations.

Authors:  B Costall; R J Naylor
Journal:  Br J Pharmacol       Date:  1995-12       Impact factor: 8.739

Review 3.  Trazodone. A review of its pharmacology, therapeutic use in depression and therapeutic potential in other disorders.

Authors:  M Haria; A Fitton; D McTavish
Journal:  Drugs Aging       Date:  1994-04       Impact factor: 3.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.